The Committee on the Evaluation of the Addition of Ingredients New to Infant Formula was convened by the Institute of Medicine to provide U.S. Food and Drug Administration and Health Canada with a critical analysis of the current methods and to recommend tools and improved methods used to evaluate the safety of ingredients new to infant formula.